logoWeightGone
Wegovy (Semaglutide)

Wegovy (Semaglutide)

by Novo Nordisk

£125.00£31.25 per week

Eligible for BMI of 30 kg/m2 or more

Features

  • Reduces appetite
  • Weekly injection
  • Lose up to 15% weight
  • FDA Approved

What is Wegovy?

Wegovy is an injectable prescription medicine used for chronic weight management in adults with obesity or overweight. It contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and calorie intake.

In clinical trials, Wegovy helped patients lose an average of 15% of their body weight when combined with lifestyle changes. The medication follows a carefully structured dose escalation schedule to help your body adjust and minimize side effects.

Wegovy is suitable for adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol).

dosages

How to Take Wegovy

  • Our clinicians will create a personalized treatment plan for you
  • Inject once weekly on the same day each week
  • Rotate injection sites (abdomen, thigh, or upper arm)
  • Follow the recommended dose escalation schedule

Dosing Schedule

Wegovy treatment begins with a 4-week dose escalation period, starting at 0.25mg and stepping up the dose every 4 weeks before reaching the maintenance dose of 2.5mg weekly. This gradual increase helps minimize side effects.

Start your weight-loss journy with Wegovy

Wegovy is a prescription-only medication. You'll need to complete a consultation with one of our healthcare professionals to determine if it's suitable for you.